☆ 4.6 Article

Non-Small-Cell Lung Cancer with HER2 Exon 20 Mutation Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment

JOURNAL OF THORACIC ONCOLOGY (2013)

Get Full Text
Add to Collection

Journal

JOURNAL OF THORACIC ONCOLOGY
Volume 8, Issue 2, Pages E19-E20

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/JTO.0b013e31827ce38e

Keywords

-

Categories

Oncology Respiratory System

Funding

  1. GlaxoSmithKline
  2. National Center for Research Resources, a component of the NIH Roadmap for Medical Research [RR024148]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.